|
RNFT1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62458935193399E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.60690358189208E-11 |
| Normal-vs-Stage2 |
9.553300E-04 |
| Normal-vs-Stage3 |
1.384790E-03 |
| Normal-vs-Stage4 |
4.091900E-02 |
| Stage1-vs-Stage2 |
5.993400E-01 |
| Stage1-vs-Stage3 |
6.662800E-01 |
| Stage1-vs-Stage4 |
7.028800E-01 |
| Stage2-vs-Stage3 |
4.142000E-01 |
| Stage2-vs-Stage4 |
4.631600E-01 |
| Stage3-vs-Stage4 |
9.145000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.63125069008174E-12 |
| Normal-vs-AfricanAmerican |
1.60090000000945E-06 |
| Normal-vs-Asian |
5.135500E-02 |
| Caucasian-vs-AfricanAmerican |
8.364200E-01 |
| Caucasian-vs-Asian |
2.719200E-01 |
| AfricanAmerican-vs-Asian |
2.452600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62714286489063E-12 |
| Normal-vs-Female |
9.70939995070808E-09 |
| Male-vs-Female |
2.119200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.839120E-03 |
| Normal-vs-Extreme_Weight |
1.41140000020634E-07 |
| Normal-vs-Obese |
2.05710000000803E-06 |
| Normal-vs-Extreme_Obese |
4.067700E-02 |
| Normal_Weight-vs-Extreme_Weight |
6.378800E-01 |
| Normal_Weight-vs-Obese |
5.302000E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.484400E-01 |
| Extreme_Weight-vs-Obese |
8.086800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.477600E-01 |
| Obese-vs-Extreme_Obese |
8.548200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.78300000000165E-05 |
| Normal-vs-Age(41-60Yrs) |
1.62725388719309E-12 |
| Normal-vs-Age(61-80Yrs) |
2.97040003705007E-09 |
| Normal-vs-Age(81-100Yrs) |
6.426200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.703000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.286200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.342900E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.984400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.063300E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.062150E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62458935193399E-12 |
| Normal-VS-Type2 PRCC |
1.020380E-03 |
| Normal-VS-KIRP CIMP |
1.255980E-02 |
| Normal-VS-Unclassified PRCC |
2.18180000000068E-05 |
| Type1 PRCC-VS-Type2 PRCC |
1.738610E-03 |
| Type1 PRCC-VS-KIRP CIMP |
3.225400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.747800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.688000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.725600E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.760800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.9994000001804E-07 |
| Normal-vs-N1 |
4.998400E-03 |
| Normal-vs-N2 |
3.934000E-01 |
| N0-vs-N1 |
9.850000E-01 |
| N0-vs-N2 |
6.258800E-01 |
| N1-vs-N2 |
7.057800E-01 |
|
|
